Thomas P. Kelly
2021
Compensation breakdown
| Non-Equity Incentive Plan | $167,432 |
|---|---|
| Option Awards | $2,103,820 |
| Salary | $465,088 |
| Stock Awards | $632,922 |
| Other | $11,600 |
| Total | $3,380,862 |
Kelly received $2.1M in option awards, accounting for 62% of the total pay in 2021.
Kelly also received $167.4K in non-equity incentive plan, $465.1K in salary, $632.9K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Thomas P. Kelly's compensation ranked 3,958th out of 12,405 executives tracked by ExecPay. In other words, Kelly earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,958 out of 12,405 | 68th |
Division Manufacturing | 1,619 out of 5,494 | 71st |
Major group Chemicals And Allied Products | 667 out of 2,369 | 72nd |
Industry group Drugs | 592 out of 2,090 | 72nd |
Industry Pharmaceutical Preparations | 413 out of 1,537 | 73rd |
Pay ratio
| Thomas P. Kelly's Pay | $3,380,862 |
|---|---|
| Median Employee's Pay | $290,520 |
| Pay Ratio | 12to 1 |
In 2021, the annual total compensation of Thomas P. Kelly was $3,380,862.
The annual total compensation of the median employee at Deciphera Pharmaceuticals was $290,520.
The ratio of Thomas P. Kelly's pay to the pay of median employee was therefore 12 to one.
Kelly's colleagues
We found four more compensation records of executives who worked with Thomas P. Kelly at Deciphera Pharmaceuticals in 2021.